Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ling

Showing results (161-170 of 317) with videos related to

Pageof 32
Sort By:
Cancer Surveys|January 1, 1986
Multidrug resistanceJ H Gerlach, N Kartner, D R Bell, et al.
Cancer Research|May 15, 1987
Generation of drug-resistant variants in metastatic B16 mouse melanoma cell linesC Cillo, J E Dick, V Ling, et al.
Journal of the American Veterinary Medical Association|July 1, 1970
Polycythemia vera in a catC Reed, G V Ling, D Gould, et al.
The Journal of Biological Chemistry|July 25, 1991
Isolation and characterization of a succinimide variant of methionyl human growth hormoneG Teshima, J T Stults, V Ling, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1976
Antisera against electrophoretically purified tubulin stimulate colchicine-binding activityJ E Aubin, L Subrahmanyan, V I Kalnins, et al.
Journal of Cellular Physiology|November 1, 1993
Differential expression of P-glycoprotein genes in primary rat hepatocyte cultureC H Lee, G Bradley, J T Zhang, et al.
British Journal of Cancer|July 24, 2008
The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistanceM Lo, V Ling, Y Z Wang, et al.
Experimental Cell Research|June 20, 1998
Embryonic stem cells and embryoid bodies express lymphocyte costimulatory moleculesV Ling, R C Munroe, E A Murphy, et al.
Science (New York, N.Y.)|June 1, 1984
Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cellsR P Hill, A F Chambers, V Ling, et al.
Oncogene|June 1, 1993
The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53R L Zastawny, R Salvino, J Chen, et al.
Pageof 32

Showing results (161-170 of 317) with videos related to

Sort By:
Pageof 32
Cancer Surveys|January 1, 1986
Multidrug resistanceJ H Gerlach, N Kartner, D R Bell, et al.
Cancer Research|May 15, 1987
Generation of drug-resistant variants in metastatic B16 mouse melanoma cell linesC Cillo, J E Dick, V Ling, et al.
Journal of the American Veterinary Medical Association|July 1, 1970
Polycythemia vera in a catC Reed, G V Ling, D Gould, et al.
The Journal of Biological Chemistry|July 25, 1991
Isolation and characterization of a succinimide variant of methionyl human growth hormoneG Teshima, J T Stults, V Ling, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1976
Antisera against electrophoretically purified tubulin stimulate colchicine-binding activityJ E Aubin, L Subrahmanyan, V I Kalnins, et al.
Journal of Cellular Physiology|November 1, 1993
Differential expression of P-glycoprotein genes in primary rat hepatocyte cultureC H Lee, G Bradley, J T Zhang, et al.
British Journal of Cancer|July 24, 2008
The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistanceM Lo, V Ling, Y Z Wang, et al.
Experimental Cell Research|June 20, 1998
Embryonic stem cells and embryoid bodies express lymphocyte costimulatory moleculesV Ling, R C Munroe, E A Murphy, et al.
Science (New York, N.Y.)|June 1, 1984
Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cellsR P Hill, A F Chambers, V Ling, et al.
Oncogene|June 1, 1993
The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53R L Zastawny, R Salvino, J Chen, et al.
Pageof 32